CHI3L1 and asthma: For example, adenovirus vector-mediated Chi3l1 shRNA can downregulate Chi3l1 levels and alleviate eosinophilic airway inflammation, airway hyperresponsiveness, and airway mucus secretion in an asthmatic mouse model, which highlights treatment prospects for human asthma [293].